Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Palisade Bio (PALI) Return on Assets (2016 - 2025)

Palisade Bio (PALI) has disclosed Return on Assets for 15 consecutive years, with 1.68% as the latest value for Q3 2025.

  • On a quarterly basis, Return on Assets fell 36.0% to 1.68% in Q3 2025 year-over-year; TTM through Sep 2025 was 1.68%, a 36.0% decrease, with the full-year FY2024 number at 1.19%, down 32.0% from a year prior.
  • Return on Assets was 1.68% for Q3 2025 at Palisade Bio, down from 1.63% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.45% in Q3 2021 to a low of 1.87% in Q1 2021.
  • A 5-year average of 1.1% and a median of 0.98% in 2022 define the central range for Return on Assets.
  • Peak YoY movement for Return on Assets: plummeted -97bps in 2021, then soared 126bps in 2022.
  • Palisade Bio's Return on Assets stood at 0.45% in 2021, then plummeted by -116bps to 0.98% in 2022, then increased by 14bps to 0.84% in 2023, then tumbled by -75bps to 1.47% in 2024, then dropped by -14bps to 1.68% in 2025.
  • Per Business Quant, the three most recent readings for PALI's Return on Assets are 1.68% (Q3 2025), 1.63% (Q2 2025), and 1.42% (Q1 2025).